Food: An Unrecognized Source of Loop Diuretic Resistance

Pharmacotherapy

Volumn 24, Issue 5 I, 2004, Pages 630-637

  Bard, Robert L ^a   Bleske, Barry E ^a   Nicklas, John M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Bumetanide; Edema; Furosemide; Loop diuretics; Torsemide

Indexed keywords

BUMETANIDE; ETACRYNIC ACID; FUROSEMIDE; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; TORASEMIDE;

CARBOHYDRATE DIET; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG RESISTANCE; EDEMA; FOOD DRUG INTERACTION; HUMAN; PHARMACODYNAMICS; REVIEW; URINE VOLUME;

ADMINISTRATION, ORAL; AREA UNDER CURVE; BUMETANIDE; CLINICAL TRIALS; DIURESIS; DIURETICS; FOOD; FUROSEMIDE; HUMANS; INTESTINAL ABSORPTION; SULFONAMIDES;

EID: 2342614748     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.6.630.34736     Document Type: Review

References (26)

1. Paintaud G, Alvan G, Eckernas SA, Wakelkamp M, Grahnen A. The influence of food intake on the effect of two controlled release formulations of furosemide. Biopharm Drug Dispos 1995;16(3):221-32.
2. Ponto LL, Schoenwald RD. Furosemide (frusemide). A pharmacokinetic-pharmacodynamic review (part I). Clin Pharmacokinet 1990;18(5):381-408.
3. Hammarlund MM, Odlind B, Paalzow LK. Acute tolerance to furosemide diuresis in humans: pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 1985;233(2):447-53.
4. Anonymous. Loop diuretics. Physicians' desk reference, 55th ed. Montvale, NJ: Medical Economics, 2001.
5. Micromedex. Furosemide. In: DrugPoints system, vol 117. Greenwood Village, CO: Micromedex healthcare series, 1998.
6. Homeida M, Hunter K, Roberts C. Delayed response to oral bumetanide given after a meal. Br J Clin Pharmacol 1976;30:969-70.
7. Kelly MR, Cutler RE, Forrey AW, Kimpel BM. Pharmacokinetics of orally administered furosemide. Clin Pharmacol Ther 1974;15(2):178-86.
8. McCrindle JL, Li Kam Wa TC, Barron W, Prescott LF. Effect of food on the absorption of furosemide and bumetanide in man. Br J Clin Pharmacol 1996;42(6):743-6.
9. Ogata H, Kawatsu Y, Maruyama Y, Machida K, Haga T. Bioavailability and diuretic effect of furosemide during long-term treatment of chronic respiratory failure. Eur J Clin Pharmacol 1985;28(1):53-9.
10. Beermann B, Midskov C. Reduced bioavailability and effect of furosemide given with food. Eur J Clin Pharmacol 1986;29(6):725-7.
11. Kramer WG. Effect of food on the pharmacokinetics and pharmacodynamics of torsemide. Amer J Ther 1995;2:499-503.
12. Brater DC, Chennavasin P, Seiwell R. Furosemide in patients with heart failure: shift in dose-response curves. Clin Pharmacol Ther 1980;28(2):182-6.
13. Brater DC, Day B, Burdette A, Anderson S. Bumetanide and furosemide in heart failure. Kidney Int 1984;26(2):183-9.
14. Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985;102(3):314-18.
15. Hammarlund-Udenaes M, Benet LZ. Furosemide pharmacokinetics and pharmacodynamics in health and disease: an update. J Pharmacokinet Biopharm 1989;17(1):1-46.
16. Kramer WG. Pharmacokinetics and pharmacodynamics of torsemide in congestive heart failure. Cardiol 1994;84(suppl 2):108-14.
17. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 1995;57(6):601-9.
18. Brater DC, Seiwell R, Anderson S, Burdette A, Dehmer GJ, Chennavasin P. Absorption and disposition of furosemide in congestive heart failure. Kidney Int 1982;22(2):171-6.
19. Ponto LL, Schoenwald RD. Furosemide (frusemide). A pharmacokinetic-pharmacodynamic review (part II). Clin Pharmacokinet 1990;18(6):460-71.
20. Benet LZ. Pharmacokinetics-pharmacodynamics of furosemide in man: a review. J Pharmacokinet Biopharm 1979;7(1):1-27.
21. Benowitz NL, Meister W. Pharmacokinetics in patients with cardiac failure. Clin Pharmacokinet 1976;1(6):389-405.
22. Greither A, Goldman S, Edelen JS, Benet LZ, Cohn K. Pharmacokinetics of furosemide in patients with congestive heart failure. Pharmacology 1979;19(3):121-31.
23. Johnston D, Duffin D. Drug-patient interactions and their relevance in the treatment of heart failure. Amer J Cardiol 1992;70(10):109C-12.
24. Oberbauer R, Krivanek P, Turnheim K. Pharmacokinetics and pharmacodynamics of the diuretic bumetanide in the elderly. Clin Pharmacol Ther 1995;57(1):42-51.
25. Barr WH, Smith H, Karnes H, et al. Comparison of bioavailability, pharmacokinetics and pharmacodynamics of torsemide in young and elderly healthy volunteers. Prog Pharmacol Clin Pharmacol 1990;8:15-28.
26. Brater DC. Resistance to loop diuretics: why it happens and what to do about it. Drugs 1985;30(5):427-43.